ArticleCell discovery2018
A novel antibody-TCR (AbTCR) platform combines Fab-based antigen recognition with gamma/delta-TCR signaling to facilitate T-cell cytotoxicity with low cytokine release.
Yiyang Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
81 papers cite itlatest 60 shown
this paperpooled itcites it